SOLICITATION NOTICE
Q -- Surveillance for Influenza Antiviral Resistance Among Hospitalized Stem Cell Transplant Patients Treated with Antiviral Agents
- Notice Date
- 5/23/2011
- Notice Type
- Presolicitation
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 2011-N-13423
- Point of Contact
- Lisa D Brown, Phone: (770)488-2646
- E-Mail Address
-
tdc0@cdc.gov
(tdc0@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- The Centers for Disease Control and Prevention (CDC) intends to competitively award a contract which provides support for the development of surveillance for antiviral drug resistance among collaborative centers caring for allogeneic stem cell transplant patients hospitalized with influenza infection. Surveillance will identify the development of antiviral resistance during antiviral treatment, identify mutations associated with resistance, and estimate a rate of emergence of antiviral resistance while on therapy. Minimum requirements are as follows: 1. Source must has access and permission to perform medical research on hospitalized human subjects who received stem cell transplants and have influenza infection, including specimen collection; 2. must care for at least 1000 patients who received a stem cell transplant each year; and, 3. must demonstrated ability to perform diagnostic testing for influenza, and can determine both virus type and influenza A subtype. Rapid influenza diagnostic tests are not acceptable. Ability to store isolates at -70◦C. NAICS code applicable to these services is 541711, Research and Development in Biotechnology and the associated size standard is 500 employees. The solicitation will be posted to this site or about 6/3/11. All requirements, evaluation criteria, basis for contract award and proposal due date will be provided as part of the solicitation. CDC anticipates the award of a cost-reimbursement contract, with a 70-month period of performance. Offerors are expected to download all documents concerning this requirement, as no hard copies will be mailed. Questions/comments via telephone will not be honored. Offerors are advised to frequently view this website for updated posting.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2011-N-13423/listing.html)
- Place of Performance
- Address: Contractor's facility, United States
- Record
- SN02454250-W 20110525/110523234139-772462ac7b3c18fa85016fee49959dea (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |